期刊文献+

乳腺癌手术后结合药物化疗的诊治体会 被引量:4

下载PDF
导出
摘要 目的讨论如何合理有效的使用化疗药物对乳腺癌手术后病人的治疗。方法分析本院自2005年1月至2011年1月235例乳腺癌手术病人术后使用非蒽环类药物、含蒽环类药物的治疗效果。结果均随访1~5年,手术后通过不同药物的化疗方案,病人死亡率均有不同程度降低,提高了病人的无病生存期和总生存期。结论乳腺癌术后病人根据不同年龄不同体质如何合理选用不同的药物化疗方案对减少病人的死亡率至关重要。
作者 胡童
出处 《浙江创伤外科》 2012年第2期211-212,共2页 Zhejiang Journal of Traumatic Surgery
  • 相关文献

参考文献3

二级参考文献44

  • 1[22]Stewart HJ, Forrest AP, Everington D, et al. Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable bresat cancer[J]. Br J Cancer,1996,74:297
  • 2[23]Fisher B,Dignam J, Bryant J, et al. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors[J]. J Natl Cancer Inst, 1996,88:1529
  • 3[24]Klijn JGM, Blarney RW, Boccardo F, et al. Combination LHRH-agonist plus tamoxifen treatment is superior to medical castration alone in premenopausal metastatic breast cancer[J]. Breast Cancer Res Treat,1998,50:227(Abst)
  • 4[25]Dombernowsky P, Smith I, Falkson G, et al. Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate[J]. J Clin Oncol,1998,16:453
  • 5[26]Buzdar AU, Jonat W, Howell A, et al. Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carinoma:results of a suvival update based on a combined analysis of data from two mature phase Ⅲ trials[J]. Cancer,1998,83:1142
  • 6[27]Bajetta E, Zilembo N, Barni S, et al. A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse:endocrine and clinical results[J]. Ann Oncol,1997,8:649
  • 7[28]Kaufmann M, Bajetta E, Dirix LY. Survival advantage of exemestane over megestrol acetate in postmenopausal women with advanced breast cancer refractory to tamoxifen:results of a phase Ⅲ randomized double-blind study[J]. Proc Am Soc Clin Oncol,1999,18:42a
  • 8[29]Crown J, Raptis G, Hamilton N, et al. High-dose chemotherapy of breast cancer:current status and developmental strategies. Eur J Cancer,1995,31A:809
  • 9[30]O'Connell MJ, Mailliard JA, Kahn MJ, et al. Controlled trial of fluorouracil and low dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol,1997,125:246
  • 10[31]Pegram M, Lipton A, Hayes DF, t al. Phase Ⅱ study of receptor-enhanced chemosensitivity using recombinant humanized anti-p158 HER2/neu monoclonal antibody plus cisplatin in patients with HER-2/new overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol,1998,16:2659

共引文献54

同被引文献45

引证文献4

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部